Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

RVNC Investor Day PR and slide set:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 720
Posts 108,437
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--2nd Update Dow Jones News - 6/25/2019 7:34:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--Update Dow Jones News - 6/25/2019 7:02:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion Dow Jones News - 6/25/2019 6:56:00 AM
AbbVie to Acquire Allergan in Transformative Move for Both Companies PR Newswire (US) - 6/25/2019 6:42:00 AM
Allergan Receives FDA Clearance For CoolTone™ Device PR Newswire (US) - 6/24/2019 7:30:00 AM
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity PR Newswire (US) - 6/21/2019 7:30:00 AM
Ironwood & Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bo... Business Wire - 6/18/2019 4:05:00 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/17/2019 5:02:19 PM
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire (US) - 6/13/2019 7:13:00 PM
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar... PR Newswire (US) - 5/28/2019 7:30:00 AM
Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/24/2019 4:05:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/23/2019 4:18:09 PM
Allergan to Present at the Jefferies 2019 Healthcare Conference PR Newswire (US) - 5/23/2019 7:30:00 AM
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire (US) - 5/17/2019 7:30:00 AM
Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/16/2019 7:30:00 AM
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighti... PR Newswire (US) - 5/15/2019 7:30:00 AM
PatientFi® Announces Study Partnership with Allergan Business Wire - 5/15/2019 6:00:00 AM
Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference PR Newswire (US) - 5/9/2019 7:30:00 AM
Takeda Sells Eye Drug to Novartis -- WSJ Dow Jones News - 5/9/2019 3:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 5:29:05 PM
Allergan Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/7/2019 7:00:00 AM
Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the ... PR Newswire (US) - 5/6/2019 8:50:00 AM
Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire (US) - 5/3/2019 7:45:00 AM
Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Re... PR Newswire (US) - 5/3/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:52:04 PM
DewDiligence Member Level  Saturday, 04/21/18 09:24:58 AM
Re: None
Post # of 189 
RVNC Investor Day PR and slide set:

#msg-140163667
https://t.co/375njX9EXq

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist